IceCure Medical (ICCM) Free Cash Flow (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Free Cash Flow data on file, last reported at -$4.2 million in Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$4.2 million, down 4.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.7 million (down 7.49% YoY), and the FY2025 annual result was -$14.5 million, down 16.38% from the prior year.
• Free Cash Flow improved to -$4.2 million in Q1 2026 per ICCM's latest filing, from -$5.0 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$2.4 million in Q2 2024 and troughed at -$5.8 million in Q4 2022.
• A 5-year average of -$3.5 million and a median of -$3.2 million in 2023 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 123.12% in 2022, then jumped 45.22% in 2023.
• A 5-year view of Free Cash Flow shows it stood at -$5.8 million in 2022, then jumped by 45.22% to -$3.2 million in 2023, then tumbled by 31.64% to -$4.2 million in 2024, then retreated by 19.67% to -$5.0 million in 2025, then rose by 15.84% to -$4.2 million in 2026.
• Business Quant data shows ICCM's Free Cash Flow at -$4.2 million in Q1 2026, -$5.0 million in Q4 2025, and -$2.7 million in Q3 2025.